About
About Cantargia
Strategy
Business development
Management
Board of Directors
Careers
Research & development
Scientific background
Scientific concept
Our therapeutic areas
Our clinical trials
Our patents
Publications and scientific presentations
Pipeline
Investor relations
Share information
Analyst coverage
Financial reports
Financial calendar
Event calendar
Corporate governance
General meetings
Share issue
ESG
ESG
Corporate Governance
Newsroom
News and press releases
Analyses and presentations
Subscribe
Media contact
Media library
Contact
Corporate Governance Archive
Documents containing the Swedish Tax Agency's response regarding the allocation of acquisition costs in relation to Cantargia’s set off issue in 2014 and the issue of shares and warrants in connection with the listing in 2015 (in Swedish)
